» Articles » PMID: 12809358

Neuroprotective Effects of Tanshinones in Transient Focal Cerebral Ischemia in Mice

Overview
Journal Phytomedicine
Date 2003 Jun 18
PMID 12809358
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Tanshinones are the major lipid soluble pharmacological constituents of Danshen, the dried roots of Salvia miltiorrhiza Bunge (Labiatae), a well known traditional Chinese medicine used for the treatment of cerebrovascular diseases including stroke. Potential neuroprotective effects of tanshinones IIA (TsIIA) and IIB (TsIIB) were examined in adult mice subjected to transient focal cerebral ischemia caused by middle cerebral artery occlusion (MCAo). Our results revealed that TsIIA (16 mg/kg) readily penetrated the blood brain barrier reaching a peak concentration of 0.41 nmol/g brain wet weight 60 minutes after intraperitoneal injection and decreased slowly over several hours. Twenty-four hours after middle cerebral artery occlusion, brain infarct volume was reduced by 30% and 37% following treatment with TsIIA and TsIIB, respectively. The reduction in brain infarct volume was accompanied by a significant decrease in the observed neurological deficit. Tanshinones or other structurally related compounds may have potential for further development as neuroprotective drugs.

Citing Articles

Advanced application of nanotechnology in active constituents of Traditional Chinese Medicines.

Qiu C, Zhang J, Wu B, Xu C, Pang H, Tu Q J Nanobiotechnology. 2023; 21(1):456.

PMID: 38017573 PMC: 10685519. DOI: 10.1186/s12951-023-02165-x.


Enhanced Sestrin expression through Tanshinone 2A treatment improves PI3K-dependent inhibition of glioma growth.

Schaf J, Shinhmar S, Zeng Q, Pardo O, Beesley P, Syed N Cell Death Discov. 2023; 9(1):172.

PMID: 37202382 PMC: 10195868. DOI: 10.1038/s41420-023-01462-6.


Mechanism of . for the Treatment of Ischemic Stroke Based on Bioinformatics and Network Pharmacology.

Wu J, Li M, Li A, Ji X Evid Based Complement Alternat Med. 2022; 2022:1767421.

PMID: 36133785 PMC: 9484879. DOI: 10.1155/2022/1767421.


Potential pre-activation strategies for improving therapeutic efficacy of mesenchymal stem cells: current status and future prospects.

Li M, Jiang Y, Hou Q, Zhao Y, Zhong L, Fu X Stem Cell Res Ther. 2022; 13(1):146.

PMID: 35379361 PMC: 8981790. DOI: 10.1186/s13287-022-02822-2.


Intracisternal administration of tanshinone IIA-loaded nanoparticles leads to reduced tissue injury and functional deficits in a porcine model of ischemic stroke.

Waters E, Kaiser E, Yang X, Fagan M, Scheulin K, Jeon J IBRO Neurosci Rep. 2021; 10:18-30.

PMID: 33842909 PMC: 8019951. DOI: 10.1016/j.ibneur.2020.11.003.